DxTerity Diagnostics' Convertible Note Round

DxTerity Diagnostics raised a round of funding on February 08, 2012.

DxTerity Diagnostics is a biotechnology company focused on utilizing the NEAT platform to provide a pathway to incorporate genetic testing and complex gene signatures into routine medical care.…

Articles about DxTerity Diagnostics' Convertible Note Round: